| G-36 |
G-36;G36;G 36 |
1392487-51-2 |
| HUMAN ACTIVIN A |
HUMAN ACTIVIN A |
1381885-28-4 |
| Dodoviscin H |
(-)-5,7-二羟基-2-[4-羟基-3-(4-羟基-3-甲基丁基)-5-(3-甲基-2-丁烯-1-基)苯基]-3-甲氧基-4H-1-苯并吡喃-4-酮 |
1372527-39-3 |
| Dodoviscin A |
DODOVISCIN A |
1372527-25-7 |
| Dodoviscin I |
(+)-5,7-二羟基-2-[4-羟基-3-(4-羟基-3-甲基丁基)苯基]-3-甲氧基-4H-1-苯并吡喃-4-酮 |
1372527-40-6 |
| YH239-EE |
[N/A] |
1364488-67-4 |
| ML-228 |
KC7F2 |
1357171-62-0 |
| UNC569 |
CS-2399 |
1350547-65-7 |
| PF-04554878 |
DEFACTINIB (VS-6063, PF-04554878) |
1345713-71-4 |
| ML224 |
CS-1585 |
1338824-21-7 |
| Osilodrostat(LCI699) phosphate |
LCI 699;LCI-699 |
1315449-72-9 |
| (S)-2-nitro-6-((6-(4-(trifluoroMethoxy)phenyl)pyridin-3-yl)Methoxy)-6,7-dihydro-5H-iMidazo[2,1-b][1,3]oxazine |
TBA-354 |
1257426-19-9 |
| GEN272 |
1936428-93-1 |
1936428-93-1 |
| RN486 |
RN 486 |
1242156-23-5 |
| BDA-366 |
BDA-366 |
1821496-27-8 |
| PRN-1371 |
PRN1371 |
1802929-43-6 |
| HM-61713 (BI-1482694) |
HM-61713(BI-1482694) |
1802181-20-9 |
| EL-102 |
1233948-61-2 |
1233948-61-2 |
| Tatariid A |
(2R)-2-羟基-1-(2,4,5-三甲氧基苯基)-1-丙酮 |
1229005-35-9 |
| EPZ020411 |
EPZ020411 盐酸盐的形式 |
1700663-41-7 |
